Intranasal insulin improves mitochondrial function and attenuates motor deficits in a rat 6-OHDA model of Parkinson's disease.
Farideh IravanpourLeila DargahiMohsen RezaeiMasoud HaghaniReza HeidariNeda ValianAbolhassan AhmadianiPublished in: CNS neuroscience & therapeutics (2021)
Considering the prominent role of mitochondrial dysfunction in PD pathology, IN insulin as a disease-modifying therapy for PD should be considered for extensive research.